Pharnext SA banner

Pharnext SA
PAR:ALPHA

Watchlist Manager
Pharnext SA Logo
Pharnext SA
PAR:ALPHA
Watchlist
Price: 0.0002 EUR
Market Cap: €1.2k

Profitability Summary

Pharnext SA's profitability score is 65/100. We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

65/100
Profitability
Score

We take all the information about a company's profitability (such as its margins, capital efficiency, free cash flow generating ability, and more) and consolidate it into one single number - the profitability score. The higher the profitability score, the more profitable the company is.

65/100
Profitability
Score
65/100
Profitability
Score

Margins

Earnings Waterfall
Pharnext SA

Margins Comparison
Pharnext SA Competitors

Country Company Market Cap Operating
Margin
Net
Margin
FR
Pharnext SA
PAR:ALPHA
1.2k EUR
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
402.1B USD
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
203.2B USD
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
182B USD
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
69.4B AUD
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.3B EUR
Loading...
Loading...

Return on Capital

Return on Capital Comparison
Pharnext SA Competitors

Country Company Market Cap ROE ROA ROCE ROIC
FR
Pharnext SA
PAR:ALPHA
1.2k EUR
Loading...
Loading...
Loading...
Loading...
FR
Pharnext SCA
OTC:PNEXF
6T USD
Loading...
Loading...
Loading...
Loading...
US
Abbvie Inc
NYSE:ABBV
402.1B USD
Loading...
Loading...
Loading...
Loading...
US
Amgen Inc
NASDAQ:AMGN
203.2B USD
Loading...
Loading...
Loading...
Loading...
US
Gilead Sciences Inc
NASDAQ:GILD
182B USD
Loading...
Loading...
Loading...
Loading...
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
117.1B USD
Loading...
Loading...
Loading...
Loading...
US
Epizyme Inc
F:EPE
94.1B EUR
Loading...
Loading...
Loading...
Loading...
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
82.6B USD
Loading...
Loading...
Loading...
Loading...
AU
CSL Ltd
ASX:CSL
69.4B AUD
Loading...
Loading...
Loading...
Loading...
US
Seagen Inc
F:SGT
39.3B EUR
Loading...
Loading...
Loading...
Loading...
NL
argenx SE
XBRU:ARGX
39.3B EUR
Loading...
Loading...
Loading...
Loading...

Free Cash Flow

Free Cash Flow Analysis
Pharnext SA

Last Value
3-Years Average
FCF Margin
Conversion Rate
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett